[Results of 16-year use of the 06-Paris-LA-66 program in the treatment of children with acute lymphoblastic leukemia].
The treatment of children with acute lymphoblastic leukemia was conducted with the use of 06-Paris-LA-66 program modified by the authors. Complete remission was obtained in 91.8% of cases. Recovery was achieved and the therapy was discontinued in 16 out of 34 patients who had strictly adhered the program treatment, the treatment of 7 patients in complete remission is continued. The authors consider the program as high efficient and recommend its use.
Mendeleev
I M
IM
Kovrigina
T I
TI
Polezhaev
Iu N
IuN
D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003630:Daunorubicin / Q000008:administration & dosage*; D006801:Humans; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D011239:Prednisolone / Q000008:administration & dosage*; D012074:Remission Induction; D013997:Time Factors; D014750:Vincristine / Q000008:administration & dosage*
D014750:Vincristine; D011239:Prednisolone; D003630:Daunorubicin
Rezul'taty 16-letnego primeneniia programmy 06-Paris-LA-66 dlia lecheniia deteĭ, bol'nykh ostrym limfoblastnym leĭkozom.